Eyeing Rapid Growth, InforSense Raises $10M in Financing, Lands First OEM Deal with Thermo | GenomeWeb
Armed with $10 million of fresh venture capital, workflow analytics firm InforSense plans to rapidly expand over the next year or so, company officials told BioInform this week.
The company this week also said it has penned an OEM deal with Thermo Electron — its first under a new initiative to expand its reach through bundling agreements with instrumentation and content providers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.